- Report ID: BMRC 1455 | Number of pages: 200 | Publish Date: Feb 2021
Status: Published | Category: Healthcare | Delivery Timeline: 48 hrs
Global Menopause Treatment Market is valued at USD 2406.0 Million in 2017 and expected to reach USD 3049.97 Million by 2027 with a CAGR of 2.4% over the forecast period.
Global Menopause Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Changing lifestyle and increasing awareness among middle aged women are key driving factors for the growth of Global Menopause Treatment Market.
Menopause is a natural process which marks the end of menstrual cycles and it is also known as Climacteric. It can also be associated by decrease in estrogen and progesterone levels. The typical age for experiencing menopause is 45 – 55 years and varies individually. Some women will find it difficult while going through this stage; symptoms include weight gain, hot flashes, and vaginal dryness. These symptoms continue for around 4 years after last period and for 12 years for around 10% of women. Menopause requires treatment for relieving the signs and preventing the chronic conditions related to it or occurs due to aging. In order to curb these symptoms there is a growing demand in medication and technology which can be the key benefits in menopause treatment market.
Global Menopause Treatment Market report is segmented on the basis of non-hormonal treatment, hormonal treatment, distribution channel and region & country level. Based on the non-hormonal treatment, the menopause treatment market is segmented into progesterone, estrogen and combination. Based upon hormonal treatment type, Global Menopause Treatment Market is classified into anti-migraine, anti-depressants, and anti-anxiety. Based upon distribution channel Global Menopause Treatment Market fragmented into Retail Pharmacies, online pharmacies, and hospital pharmacies.
The regions covered in this Global Menopause Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Menopause Treatment is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia, Africa, etc.
Some major key players for Global Menopause Treatment Market are Fervent Pharmaceuticals, Pfizer, Merck, Novartis, Novo Nordisk, Cipla, Emcure Pharmaceuticals, Allergen plc, Teva Pharmaceuticals and others.
News: New Telemedicine Service
July 15th, 2020; The Cusp, new startup offering telemedicine services to predict the menopause. These services include, at-home hormone tests reducing the hospitals and labs costs. The telemedicine will cost up to $159 comparatively less with $500 for lab test and hospital consultations. The Cusp is providing care to around 200 patients and expanding its launch with other startups like CurieMD, Elektra Health and Geneve. Till date, company has raised around $4 million from the investors.
The major factor driving the growth of global menopause treatment market is awareness among middle aged women and their changing lifestyles. On the other hand, there is tremendous growth in menopausal symptoms and it is estimated that around 80% of women experience common symptoms like mood change, joint pain, headaches, hot flashes and night sweats. Therefore, NICE has recommended Hormone Replacement Therapy (HRT) for hot flashes and night sweats. Moreover, rising investment in R&D activities along with new product launches in the market is expected to fuel the growth of menopause treatment market. In some developing countries, discussing about menstrual cycles considered as taboo as well as lack of developed healthcare infrastructure is expected to hamper the growth of menopause treatment market. In addition, herbal and natural treatment options turn out to be the major opportunity and support the market growth in a long run.
North America is expected to dominate the Global Menopause Treatment Market within the forecast period attributed to the presence of developed healthcare infrastructure and supportive government initiatives for women’s health. Moreover, surge in female population with menopause symptoms are also likely to raise the demand for treatment. According to the study published in journal of The North America Menopause Society (NAMS) the symptoms of menopause is correlated with job environment which affects the working women aged between 45 to 65 years. These symptoms affect them physically, psychologically and sexually. Furthermore, growth in R&D investment and development of novel treatment options are also expected to enhance the market growth.
Europe is the second largest developed region in menopause treatment market followed by North America. Asia Pacific is expected to develop at significant rate owing to surge in working female population supported by rising awareness. IN addition, increase in strategic collaborations in the region is also expected to fuel the market growth. Moreover, growth in technology and development in healthcare infrastructure is also expected to contribute the overall market growth.
By Non-Hormonal Treatment:
By Hormonal Treatment:
By Distribution Channel:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Interested in this report?
Menopause Treatment Market Size By Non-Hormonal Treatment (Progesterone, Estrogen, Combination), By Hormonal Treatment (Anti-Migraine, Anti-Depressants, Anti-Anxiety), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies), Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027